---
title: "ABK Biomedical announce first patient treated in Y90 radioembolization study"
date: "2023-10-24T15:58:42.000Z"
publishedDate: "24 octobre 2023"
summary: "ABK Biomedical, a medical device company dedicated to the research, development, and commercialisation of advanced imageable embolic medical devices, has announced the first patient treated in its Route90 US investigation device exemption (IDE) pivotal study. The Eye90 microspheres radioembolization procedure was performed by Eric A Wang (Charlotte Radiology, Charlotte, USA)."
importance: ""
sourceUrl: "https://interventionalnews.com/abk-biomedical-announce-first-patient-treated-in-y90-radioembolization-study/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-10-24-abk-biomedical-announce-first-patient-treated-in-y90-radioembolization-study"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2018/07/ABK-Biomedical.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/abk-biomedical-announce-first-patient-treated-in-y90-radioembolization-study/"
---

![ABK Biomedical announce first patient treated in Y90 radioembolization study](https://interventionalnews.com/wp-content/uploads/sites/13/2018/07/ABK-Biomedical.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/abk-biomedical-announce-first-patient-treated-in-y90-radioembolization-study/*

## L’essentiel

ABK Biomedical, a medical device company dedicated to the research, development, and commercialisation of advanced imageable embolic medical devices, has announced the first patient treated in its Route90 US investigation device exemption (IDE) pivotal study. The Eye90 microspheres radioembolization procedure was performed by Eric A Wang (Charlotte Radiology, Charlotte, USA).

## Lien source

https://interventionalnews.com/abk-biomedical-announce-first-patient-treated-in-y90-radioembolization-study/
